Bowen, Michael,Wu, Herren,Dall'Acqua, William,Kiener, Peter,Jallal, Bahija,Coyle, Anthony,DallAcqua, William
申请号：
AU2010208125
公开号：
AU2010208125B2
申请日:
2010.01.29
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention provides human anti-IL-6 antibodies with extended in vivo half-life. The invention further relates to pharmaceutical compositions, therapeutic compositions, and methods using therapeutic antibodies that bind to IL-6 and that has an extended in vivo half-life for the treatment and prevention of IL-6 mediated diseases and disorders, such as, but not limited to, inflammatory diseases and disorders, autoimmune diseases and disorders and tumors.
